BRISBANE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases (and ...
BRISBANE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new ...
Researchers have developed the first synthetic method to make proteins with nitrated versions of tyrosine in specific sites. The method may make it easier to study how α-synuclein, a protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results